Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Vion initiates Cloretazine trials in combination with stem cell transplantation

Dec. 11, 2007

EntreMed initiates phase II study with MKC-1 in pancreatic cancer

Dec. 11, 2007

Discovery, preclinical and clinical activity of INCB-018424 described

Dec. 11, 2007

FDA Oncologic Drugs Advisory Committee rejects Genentech's Avastin for breast cancer

Dec. 10, 2007

SGX submits IND application to FDA for SGX-523

Dec. 10, 2007

Ipsogen undertakes pilot JAK2 cancer biomarker study with AstraZeneca

Dec. 10, 2007

Inhibiton's ICA-1 compound effective in in vitro testing in various cancer cell lines

Dec. 10, 2007

Nippon Kayaku initiates phase II study of NK-105

Dec. 7, 2007

In vivo antimetastatic activity of novel irreversible uPA inhibitors

Dec. 7, 2007

OncoVista licenses OSI-7904L from OSI Pharmaceuticals

Dec. 7, 2007

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...